Novocure Shares Owned By Institutions vs. Cash And Equivalents
| NVCR Stock | USD 31.54 0.56 1.74% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.49 | 0.7481 |
|
|
For Novocure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novocure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novocure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novocure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novocure over time as well as its relative position and ranking within its peers.
Novocure |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novocure. If investors know Novocure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novocure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share (1.39) | Revenue Per Share 5.375 | Quarterly Revenue Growth 0.218 | Return On Assets (0.08) |
The market value of Novocure is measured differently than its book value, which is the value of Novocure that is recorded on the company's balance sheet. Investors also form their own opinion of Novocure's value that differs from its market value or its book value, called intrinsic value, which is Novocure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novocure's market value can be influenced by many factors that don't directly affect Novocure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novocure's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novocure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novocure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Novocure Cash And Equivalents vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Novocure's current stock value. Our valuation model uses many indicators to compare Novocure value to that of its competitors to determine the firm's financial worth. Novocure is rated below average in shares owned by institutions category among its peers. It is considered to be number one stock in cash and equivalents category among its peers creating about 9,789,658 of Cash And Equivalents per Shares Owned By Institutions. Comparative valuation analysis is a catch-all technique that is used if you cannot value Novocure by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Novocure Cash And Equivalents vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Novocure |
| = | 96.89 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Novocure |
| = | 948.52 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Novocure Cash And Equivalents Comparison
Novocure is currently under evaluation in cash and equivalents category among its peers.
Novocure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Novocure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novocure will eventually generate negative long term returns. The profitability progress is the general direction of Novocure's change in net profit over the period of time. It can combine multiple indicators of Novocure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -5.5 M | -5.2 M | |
| Operating Income | -232.9 M | -221.2 M | |
| Net Loss | -207 M | -196.7 M | |
| Income Before Tax | -191.7 M | -182.2 M | |
| Total Other Income Expense Net | 41.1 M | 43.2 M | |
| Net Loss | -106.4 M | -111.7 M | |
| Net Loss | -207 M | -196.7 M | |
| Income Tax Expense | 15.3 M | 16.1 M | |
| Interest Income | 19.6 M | 20.6 M | |
| Net Interest Income | 41.9 M | 44 M | |
| Change To Netincome | 120.4 M | 126.4 M | |
| Net Loss | (1.95) | (1.85) | |
| Income Quality | 0.35 | 0.39 | |
| Net Income Per E B T | 1.08 | 0.87 |
Novocure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Novocure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novocure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novocure's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Novocure without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Use Investing Themes to Complement your Novocure position
In addition to having Novocure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 439 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Novocure Stock Analysis
When running Novocure's price analysis, check to measure Novocure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novocure is operating at the current time. Most of Novocure's value examination focuses on studying past and present price action to predict the probability of Novocure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novocure's price. Additionally, you may evaluate how the addition of Novocure to your portfolios can decrease your overall portfolio volatility.